Jefferies analyst Akash Tewari lowered the price target on Eli Lilly (NYSE: LLY) to $905.00 (from $1,057.00) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE